Take 2: What the Results Will be AboutLet's try to paste this again, hopefully without all the stupid symbols (if they show up again, just ignore them). This is from a newspaper earlier this month:
"The pharmaceutical company is putting PhG-alpha-1 through its paces at the Ottawa Hospital Research Institute and the U.S. National Cancer Research Institute (NCI).
The Ottawa Hospital's results on ovarian cancer cell treatment will be released during the first week of August, with the institute also planning to ramp up its test program to a second phase examining PhG-alpha-1's effectiveness in slowing ovarian cancer cell invasion and mobility.
Later that month, the NCI will release its analysis on the drug's ability to treat a variety of cancers ranging from breast, to kidney, to leukemia."